MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0077913
Bachxen Pharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹38.61 Lakh
▲ 80% YoY
Net profit · FY 2025
₹3.14 Lakh
Net margin 8.1%
EBITDA · FY 2025
₹3.23 Lakh
EBITDA margin 8.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Bachxen Pharmaceuticals Private Limited
Data last updated:
Bachxen Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC318191. Its GSTIN is 27AAICB1641B1Z6 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mayuresh Suresh Nirmal and Jessy Penattinmootil Mathai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 Vrindavan Chs Sector 20 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.61 Lakh, a growth of 80% compared to the previous year. For the same year it recorded a net profit of ₹3.14 Lakh (net margin 8.1%) and EBITDA of ₹3.23 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 5% over five years.
Bachxen Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0077913). For more details, the company can be reached via its website bachxen.com.
Company details
CIN U74999MH2018PTC318191
Registration Number 318191
Incorporation Date 12 December 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0077913
Recognitions & Rankings of Bachxen Pharmaceuticals
Contact details
Bachxen Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is bachxen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address202 Vrindavan Chs Sector 20 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bachxen Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bachxen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bachxen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bachxen Pharmaceuticals Private Limited, buy the company report.
Financials of Bachxen Pharmaceuticals Private Limited
FY 2025 filings availableBachxen Pharmaceuticals Private Limited reported revenue of ₹38.61 Lakh (up 80% YoY) for FY 2025.
Revenue · FY 2025
₹38.61 Lakh ▲ 80%
Net profit · FY 2025
₹3.14 Lakh margin 8.1%
EBITDA · FY 2025
₹3.23 Lakh margin 8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 28%
5 years · compounded
▲ 5%
EBITDA CAGR growth
3 years · compounded
▲ 30%
5 years · compounded
▲ 33%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 80% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 8.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bachxen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bachxen Pharmaceuticals Private Limited
Bachxen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayuresh Suresh Nirmal | Director | 03 Aug 2024 | 2 Years 3 Months | Current |
| Jessy Penattinmootil Mathai | Director | 03 Aug 2024 | 2 Years 3 Months | Current |
Peer comparison
Bachxen Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seawings Pharmaceuticals Private Limited | ₹38.77 Lakh (FY 2025) | 14.0% | Kota, Rajasthan, India | |||
| Zepcon Pharmaceuticals Private Limited | ₹38.75 Lakh (FY 2024) | -6.0% | Patna, Bihar, India | |||
| Cygneev Pharmaceuticals Private Limited | ₹38.74 Lakh (FY 2025) | 533.0% | Birhana Road, Uttar Pradesh, India | |||
| Bachxen Pharmaceuticals Private Limitedthis company | ₹38.61 Lakh (FY 2025) | ₹3.14 Lakh | 8.1% | 80.0% | Navi Mumbai, Maharashtra, India | |
| Pay Pharmaceuticals Private Limited | ₹38.57 Lakh (FY 2024) | 3249.0% | Panchkula, Haryana, India | |||
| Kashyap Pharmaceuticals Private Limited | ₹38.44 Lakh (FY 2024) | 86.0% | Thane, Maharashtra, India | |||
| Kithkin Pharmaceuticals Private Limited | ₹38.4 Lakh (FY 2025) | 1.0% | New Delhi, Delhi, India |
To see the full peer comparison of Bachxen Pharmaceuticals Private Limited, buy the company report.
Auditor
Bachxen Pharmaceuticals Private Limited is audited by PAYAL PUTHRAN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAYAL PUTHRAN & ASSOCIATES | FY 2019 | 144823W |
Shareholding
The shareholding of Bachxen Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bachxen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bachxen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bachxen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bachxen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICB1641B1Z6 | Maharashtra | Active | 14 Jan 2019 |
To see the full GST registrations and return filing status of Bachxen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bachxen Pharmaceuticals Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Amit Narendra Desai ceased to be Director on 05 Aug 2024.
AGM
Bachxen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bachxen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Amit Narendra Desai ceased to be Director.
Ceased
Deep Yatin Desai ceased to be Director.
Appointed
Jessy Penattinmootil Mathai was appointed as Director.
Appointed
Mayuresh Suresh Nirmal was appointed as Director.
Appointed
Amit Narendra Desai was appointed as Director.
Appointed
Deep Yatin Desai was appointed as Director.
Incorporation
12 Dec 2018
Bachxen Pharmaceuticals Private Limited was registered on 12 Dec 2018 with Roc Mumbai & aged 7 years 10 months as per MCA records.
Frequently asked questions
Bachxen Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U74999MH2018PTC318191.
Bachxen Pharmaceuticals has 2 current directors:
- Mayuresh Suresh Nirmal - Director
- Jessy Penattinmootil Mathai - Director
The latest financial statements of Bachxen Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Bachxen Pharmaceuticals is 27AAICB1641B1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bachxen Pharmaceuticals is U74999MH2018PTC318191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bachxen Pharmaceuticals was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bachxen Pharmaceuticals by revenue are Seawings Pharmaceuticals Private Limited, Zepcon Pharmaceuticals Private Limited, Cygneev Pharmaceuticals Private Limited, Pay Pharmaceuticals Private Limited, Kashyap Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Narendra Desai ceased to be Director on 05 Aug 2024. Deep Yatin Desai ceased to be Director on 05 Aug 2024. Jessy Penattinmootil Mathai was appointed as Director on 03 Aug 2024. Bachxen Pharmaceuticals has 6 board changes on record in total.
Yes, Bachxen Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0077913).
Bachxen Pharmaceuticals can be reached through the website bachxen.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Bachxen Pharmaceuticals is at 202 Vrindavan Chs Sector 20 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages